GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » Research & Development

Mainz Biomed NV (Mainz Biomed NV) Research & Development : $9.96 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Mainz Biomed NV's Research & Development for the three months ended in Dec. 2023 was $2.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $9.96 Mil.

Mainz Biomed NV Research & Development Historical Data

The historical data trend for Mainz Biomed NV's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV Research & Development Chart

Mainz Biomed NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
0.25 0.31 0.48 5.02 9.59

Mainz Biomed NV Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.32 2.63 3.48 1.86 2.00

Mainz Biomed NV Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.96 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mainz Biomed NV  (NAS:MYNZ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Mainz Biomed NV Research & Development Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Mainz Biomed NV (Mainz Biomed NV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » Research & Development
Comparable Companies
STIM AKUMQ CNTG XGN DRIO LMDX PSNL DMTK CHEK TTOO TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH
Traded in Other Exchanges
4TO:Germany
Address
Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129
Website
https://www.mainzbiomed.com
Mainz Biomed NV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. Its main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.